We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Development of a standard approach for AI and autonomy in networked multi-sensor systems in security and defence.
Information for patients, public and healthcare professionals.
Check the tariff classification for antimicrobial bathing systems.
Use this form to submit samples to test for Mycobacterium bovis antibodies in new world camelids including llamas and alpacas.
SIN support to the National Biofilms Innovation Centre led to signing two Memoranda of Understanding, strengthening UK's global position in biofilms research.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved elafibranor (Iqirvo) to treat adult patients with a rare type of liver disease known as primary biliary cholangitis (PBC).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).